PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Biotechnology and Laboratory Science in Medicine, National Yang-Ming University, Taipei, Taiwan.\', \'Departments of Infectious Disease, Far Eastern Memorial Hospital, Taipei, Taiwan.\', \'Institute of Bioinformatics and Systems Biology, National Chiao Tung University, Hsinchu, Taiwan.\', \'Department of Biological Science and Technology, College of Biological Science and Technology, National Chiao Tung University, Hsinchu, Taiwan.\', \'Center for Intelligent Drug Systems and Smart Bio-devices, National Chiao Tung University, Hsinchu, Taiwan.\', \'Faculty of Internal Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung City, Taiwan.\', \'Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung City, Taiwan.\', \'Institute of Biochemistry and Molecular Biology, National Yang-Ming University, Taipei, Taiwan.\', \'Department of Applied Science, National Tsing Hua University South Campus, Hsinchu, Taiwan.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1080/14756366.2020.1850710
?:hasPublicationType
?:journal
  • Journal of enzyme inhibition and medicinal chemistry
is ?:pmid of
?:pmid
?:pmid
  • 33430659
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.04
?:rankingScore_hIndex
  • 60
is ?:relation_isRelatedTo_publication of
?:title
  • Repurposing existing drugs: identification of SARS-CoV-2 3C-like protease inhibitors.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all